drugset / Trial / NCT03934333
A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare the systemic exposure of budesonide delivered by the combination inhaler (budesonide/albuterol sulfate pressurized inhalation suspension \[BDA metered dose inhaler {BDA MDI}\]) with Pulmicort Flexhaler dry-powder inhaler (DPI).
Timeline
- Start
- 2019-05-16
- Primary completion
- 2019-09-10
- Completion
- 2019-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Subject | Budesonide | Small molecule | 180 ug | Inhaled |
| Background | Salbutamol | Unknown | 180 ug | Inhaled |
Indications
No indication recorded.